MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517044345 A) filed by Spitfire Pharma Llc, Gaithersburg, U.S.A., on May 7, for 'therapeutic regimens and methods for treatment of cardiovascular risk factors using a glp-1r and gcgr agonist.'
Inventor(s) include Suschak III, John, Joseph; Georges, Bertrand, Victor, Gilbert; Browne, Sarah, K.; Harris, Matthew, Scott; Roberts, M. Scot; and Andrade, Maynara, Lucca.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "This disclosure relates to the once weekly dosing regimen of a dual GLP-1R and GCGR agonist, formulations, and methods of using the sam...